Based on the study “Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.”
Despite the proven effectiveness of medication for opioid use disorder (MOUD), many individuals in need never receive it. Persistent barriers, stigma, provider shortages, restrictive regulations, and poor integration into primary and specialty care, continue to limit access to treatment.
These are not just logistical obstacles. They are system-level failures that perpetuate preventable overdoses and inequities in care.
Why It Matters
The featured study, “Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder,” identifies core gaps across the treatment continuum and outlines actionable strategies to close them.
Stigma remains one of the most damaging forces. Many patients and even providers continue to view MOUD as “substituting one drug for another.” This misconception delays care and deepens shame. Compounding that stigma are regulatory burdens, such as prescribing restrictions, and a workforce stretched thin across primary care, psychiatry, and addiction medicine.
The study calls for system-level change:
more training, policy reform, integration of MOUD into general healthcare, and supportive infrastructure to help providers deliver effective, patient-centered treatment.
Key Takeaways
- Expand training and support. Increase MOUD education in medical schools, residencies, and continuing education.
- Streamline regulations. Simplify prescribing requirements to empower qualified clinicians to initiate and manage treatment.
- Normalize MOUD in healthcare. Integrate addiction treatment into primary care, emergency medicine, and mental health settings.
- Address stigma head-on. Reframe language and clinical culture to view opioid use disorder as a treatable medical condition.
- Invest in workforce development. Incentivize addiction specialization through funding, mentorship, and interdisciplinary models.
Clinical Pearl:
Every clinical setting is an opportunity for engagement. When providers integrate MOUD into routine care, treatment becomes prevention.
Beyond the Mic
In this episode, Dr. O is joined by Dr. Adina Bowe, Assistant Professor of Internal Medicine, Psychiatry, Addiction Psychiatry, and Addiction Medicine at West Virginia University and CAMC.
Dr. Bowe brings a unique dual-boarded perspective to the discussion, bridging psychiatry and internal medicine to highlight how clinicians can navigate real-world barriers with compassion, skill, and advocacy.
Together, they explore how systems can evolve to treat opioid use disorder as the chronic medical condition it is, not a moral failure, but a public health responsibility.
Featured Resources
Primary Study:
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System
NAM Perspect. 2020 Apr 27;2020:10.31478/202004b. doi: 10.31478/202004b
Related Guidance:
- SAMHSA: Medications for Opioid Use Disorder Treatment Improvement Protocol (TIP 63)
- National Academies of Medicine: “Medications for Opioid Use Disorder Save Lives”
Listen to Transformed Minds: Breaking Barriers, Expanding Access to Evidence-Based Treatment for Opioid Use Disorder with Dr. Adina Bowe for a grounded, actionable conversation on reforming addiction care. FULL EPISODE
Stay ready. Stay aware. Stay grounded.
